Alkegen has commenced a prepackaged Chapter 11 process in the US Bankruptcy Court for the Northern District of Texas, moving to implement a restructuring support agreement that will eliminate approximately $3.1 billion of the specialty-materials maker's debt. The filing carries the backing of 99% of first-lien lenders and a majority of second-lien holders, and the company has secured $315 million in committed financing to fund operations through the process.

What makes the filing notable to boards outside Alkegen's own capital structure is the timing relative to the company's history: this Chapter 11 arrives less than two years after an earlier liability-management exercise, led by Oak Hill, that was designed to resolve the same underlying debt burden without a court process. That the out-of-court fix did not hold is a data point worth weighing for any board currently relying on a liability-management exercise as a substitute for a fuller balance-sheet resolution — LME transactions can buy time, but they do not necessarily buy a permanent exit from over-leverage.

The near-unanimous first-lien support suggests the terms were negotiated well before the filing rather than contested in court, which typically points to a faster process and a more predictable outcome for trade creditors and counterparties who depend on the company's continued operations. Boards with exposure to Alkegen as a supplier, customer, or lender should treat the prepackaged structure and committed financing as evidence the company intends to keep operating through the case, but the repeat restructuring is a reminder that a first liability-management exercise does not guarantee it will be the last.

The Boardroom Report · Published by Tetmo Publishing
Subscribe · Group pricing available

Keep Reading